Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA)
clinical trials that represent both patients' and physicians' priorities. Methods We …

Objective. To include the patient perspective in accordance with the Outcome Measures in
Rheumatology (OMERACT) Filter 2.0 in the updated Psoriatic Arthritis (PsA) Core Domain Set …

Objectives—The current psoriatic arthritis (PsA) Core Domain Set defines core domains to
be measured in randomized controlled trials (RCTs) and longitudinal observational studies (…

Background/Purpose: Tobacco smoking and rheumatoid arthritis (RA) are independent risk
factors for short-term complications following total hip and total knee arthroplasty (THA/TKA). …

… MOD (P = 0.02), whereas only a trend was found in HIGH (P = … adipose tissue for either
intervention group (P > 0.1; Table 1). … (P = 0.04) and tended to decrease compared with CON (P = …

… and lactate clearance compared to non-OHCA patients (p<0.05 for all). In multivariable analysis
… However, there was no difference in the VIS score during the first 24 hours (p = 0.98, sub …

Background: Physical function is a core domain to be measured in randomized controlled
trials (RCTs) of psoriatic arthritis (PsA). The discriminative performance of patient reported …

Background: Structural damage was identified as an important outcome domain in the
Psoriatic Arthritis (PsA) Core Domain Set and should be assessed at least once in the …

… All statistical results were considered significant when p < 0.05. … was borderline significant
with SUV max in univariate analysis, p = 0.0503), which next drives an increased expression …

JERRY & KAREN BIRT JEFF & JUDY BLAYDES JUNE BRATTAIN & DALLAS NICHOLS
DAVID & JAYNE BRAY TOM & CARMEN CASH JACK RANDALL EARLES TOM & CAROL …